DDR2 and hepatocellular carcinoma: Liu et al. explored the underlying mechanism of oxaliplatin resistance and immune evasion of HCC cells and found that DDR2/STAT3-mediated CCL20 expression can drive PMN-MDSCs accumulation and promote HCC proliferation and resistance to oxaliplatin [76].